135 related articles for article (PubMed ID: 31350847)
1. HiFreSP: A novel high-frequency sub-pathway mining approach to identify robust prognostic gene signatures.
Li M; Zhao J; Li X; Chen Y; Feng C; Qian F; Liu Y; Zhang J; He J; Ai B; Ning Z; Liu W; Bai X; Han X; Wu Z; Xu X; Tang Z; Pan Q; Xu L; Li C; Wang Q; Li E
Brief Bioinform; 2020 Jul; 21(4):1411-1424. PubMed ID: 31350847
[TBL] [Abstract][Full Text] [Related]
2. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
Li W; Liu J; Zhao H
Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
[TBL] [Abstract][Full Text] [Related]
3. A signature of 33 immune-related gene pairs predicts clinical outcome in hepatocellular carcinoma.
Sun XY; Yu SZ; Zhang HP; Li J; Guo WZ; Zhang SJ
Cancer Med; 2020 Apr; 9(8):2868-2878. PubMed ID: 32068352
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value.
Lehmann BD; Ding Y; Viox DJ; Jiang M; Zheng Y; Liao W; Chen X; Xiang W; Yi Y
BMC Cancer; 2015 Mar; 15():179. PubMed ID: 25886164
[TBL] [Abstract][Full Text] [Related]
5. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
[TBL] [Abstract][Full Text] [Related]
6. Identification of 17 mRNAs and a miRNA as an integrated prognostic signature for lung squamous cell carcinoma.
Zhang J; Bing Z; Yan P; Tian J; Shi X; Wang Y; Yang K
J Gene Med; 2019 Aug; 21(8):e3105. PubMed ID: 31215090
[TBL] [Abstract][Full Text] [Related]
7. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
[TBL] [Abstract][Full Text] [Related]
8. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
[TBL] [Abstract][Full Text] [Related]
9. A signature of 14 immune-related gene pairs predicts overall survival in gastric cancer.
Zhao E; Zhou C; Chen S
Clin Transl Oncol; 2021 Feb; 23(2):265-274. PubMed ID: 32519178
[TBL] [Abstract][Full Text] [Related]
10. Protein-coding genes combined with long non-coding RNAs predict prognosis in esophageal squamous cell carcinoma patients as a novel clinical multi-dimensional signature.
Guo JC; Li CQ; Wang QY; Zhao JM; Ding JY; Li EM; Xu LY
Mol Biosyst; 2016 Oct; 12(11):3467-3477. PubMed ID: 27714034
[TBL] [Abstract][Full Text] [Related]
11. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
12. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
15. Identification and Complete Validation of Prognostic Gene Signatures for Human Papillomavirus-Associated Cancers: Integrated Approach Covering Different Anatomical Locations.
Kwon EJ; Ha M; Jang JY; Kim YH
J Virol; 2021 Feb; 95(6):. PubMed ID: 33361419
[TBL] [Abstract][Full Text] [Related]
16. Development of somatic mutation signatures for risk stratification and prognosis in lung and colorectal adenocarcinomas.
Menor M; Zhu Y; Wang Y; Zhang J; Jiang B; Deng Y
BMC Med Genomics; 2019 Jan; 12(Suppl 1):24. PubMed ID: 30704450
[TBL] [Abstract][Full Text] [Related]
17. Dual prognostic role of 2-oxoglutarate-dependent oxygenases in ten cancer types: implications for cell cycle regulation and cell adhesion maintenance.
Chang WH; Forde D; Lai AG
Cancer Commun (Lond); 2019 Apr; 39(1):23. PubMed ID: 31036064
[TBL] [Abstract][Full Text] [Related]
18. Construction and optimization of gene expression signatures for prediction of survival in two-arm clinical trials.
Theilhaber J; Chiron M; Dreymann J; Bergstrom D; Pollard J
BMC Bioinformatics; 2020 Jul; 21(1):333. PubMed ID: 32711453
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
[TBL] [Abstract][Full Text] [Related]
20. Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers.
Liu D
Breast Cancer Res Treat; 2020 Aug; 183(1):95-105. PubMed ID: 32601968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]